Apollomics Inc. (APLM) stock
APLMNasdaqPharmaceutical PreparationsFiscal year ends December 31Also trades as APLMW
$16.84−1.00 (-5.61%)
Close on Nov 17, 2026Market cap $36.98MP/E –Yield –
Apollomics operating income
Operating income is the profit from the core business after operating expenses such as R&D and selling costs, before interest and taxes.
For fiscal 2022 it was $976.00K.
Annual operating income
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2022 | Dec 31, 2022 | $976.00K | – |
See a number that looks wrong?